LunaDNA shares for four tumor whole-genome time points from the same person in a year against a single time point

300 and 1,200

ratio of shares offered, four time points a year to one, US

“DNA Tumor Whole Genome 300 4 time points/year 1,200 3 120 1,320/year ... additional files from same time point (i.e. same biopsy, different areas of tumor) may be submitted for 10 shares each to a maximum of 4 files per biopsy. Extra submissions are also allowable so long as each submission is from a different time point up to a max of 4 time points per year.”

LunaDNA, LLC, Regulation A offering circular filed with the SEC under Rule 253(g)(2), December 2021 (shares per data type table), 2021-12

Kind of source
Regulatory filing
Read on
2026-11-06
Daily check
Quote found at the source on 2026-11-06
What to know
Each new time point from the same person earns the full 300 shares of the first, so a year of four time points is worth four snapshots, while a further file from the same time point earns only 10 shares. The same rule applies to the tumor exome, genotyping and targeted panels. A buyer's own offer schedule to people, priced in shares it values itself.
Arithmetic
1,200 shares / 300 shares = 4.

Used in

Kept as evidence; no figure on the platform is computed from it yet.